Up to a maximum of $75,000; 10% of the funding can be used for indirect costs. - Friday, January 30, 2026 (LOI); Friday, June 05, 2026 (Full application, by invitation)
American Parkinson Disease Association (APDA)
This call aims to study the health inequities and/or differences among under-studied PD communities, across the spectrum of ethnicity, ancestry, geography, socioeconomic conditions, and gender.
Direct costs may not exceed $500,000 without prior approval. - June 5, 2026
National Institutes of Health (NIH)-R01 Research Project Grant*
This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis.
Up to $130,000, including 10% indirect costs, for clinical trials; and not above $110,000, including 10% indirect costs, for lab-based studies. - June 2, 2026 (pre-application)
Crohn's and Colitis Foundation of America, Inc. (CCFA)
This supports pioneering clinical and translational research focused on improving diagnosis, identifying subsets, and developing treatments for inflammatory bowel diseases (IBD).
Upper: $390,000; Total maximum award per year: $130,000 (subject to annual progress report approval). Direct Costs: up to $118,182 per year; Indirect Costs: 10% of direct costs, or up to $11,818 Duration of Award: One to Three Years Deadline: June 2, 2026 - Tuesday, June 2, 2026 (pre-application)
Crohn's and Colitis Foundation of America, Inc. (CCFA)
This supports established researchers in generating preliminary data for studies on digestive diseases, including inflammatory bowel disease, ulcers, and gastroenterology. Focuses on clinical research and medical interventions to improve understanding and treatment of gastrointestinal disorders.
SBMA Research Grants Grants: up to $100,000 are available for one or two years. Junior investigators and senior post-doctoral fellows are encouraged to apply. - June 1, 2026
Kennedys Disease Association
The Kennedy’s Disease Association (KDA) is committed to accelerating research that improves understanding, diagnosis, and treatment of Kennedy’s Disease, also known as Spinal and Bulbar Muscular Atrophy (SBMA).
Up to £250K per project - Friday, May 29, 2026 (Expression of Interest)
CANCER RESEARCH UK
This scheme accelerates the translation of laboratory discoveries into novel cancer therapeutics. It supports exploratory drug discovery focused on validating and de- risking targets, with the long-term goal of developing novel anti-tumoral single-agent therapeutics.
This initiative supports the creation of evidence infrastructure hubs in low- and middle-income countries to advance health research and policy in Climate and Health, Infectious Disease, Mental Health, or Discovery Research.
Between $25,000 and $75,000. - Friday, May 01, 2026
PCDH19 Alliance
The goal of the PCDH19 Alliance Research Grant Program is to fund research directly towards understanding the expression of the PCDH19 gene and the function of the PCDH19 protein, finding therapeutic treatments, and a cure for PCDH19 Epilepsy.
American Parkinson Disease Association (APDA)
National Institutes of Health (NIH)-R01 Research Project Grant*
Crohn's and Colitis Foundation of America, Inc. (CCFA)
Kennedys Disease Association
King Hussein Cancer Foundation and Center
CANCER RESEARCH UK
Breakthrough T1D, US
Wellcome Trust
PCDH19 Alliance
